HUBEI LONGXIANG PHARMACEUTICAL TECH.CO.,LTD.
Hubei Longxiang Pharmaceutical Technology Co., Ltd. - Startpagina
Hubei Longxiang Pharmaceutical Technology Co., Ltd. werd opgericht in januari 2008 met een maatschappelijk kapitaal van 122 miljoen yuan. De controlerende aandeelhouder is Tianjin Ruipu Biotechnology Co., Ltd. (aandelencode: 300119). Longxiang Pharmaceutical werd in april 2017 genoteerd in het nieuwe derde bestuur, aandelencode: 871082. Het heeft meer dan 340 werknemers en een balanstotaal van 560 miljoen yuan.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Wuxue, China
- Website
- https://www.lxpharm.com
- Categories
- Farmaceutische productie, Chemicaliën en kunststoffen, Veterinaire producten en diergezondheid
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
- domain-registered (green), checked 2026-08-09 Domain registry record
- debarment-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- lei-lapsed (amber), checked 2026-08-09 GLEIF
- sanctions-clear (green), checked 2026-08-09 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)